FDA Approves DaTscan Imaging
January 2011 Monthly Message
- PAN Joins Class-Action Lawsuit Against Medicare
- FDA Approves DaTscan Imaging
- Letter from Merck About Sinemet
- Register for the PAN Forum Webcast
- Parkinson's in the Media
The Food and Drug Administration (FDA) approved DaTscan, a new radiopharmaceutical agent used for brain imaging. With FDA’s approval on January 14, 2011, the Parkinson’s community now has an available brain imaging technology that can help in the diagnosis of Parkinson’s disease at an earlier stage and can help differentiate Parkinson’s from other conditions, such as essential tremor. In early 2010, the Parkinson's Action Network wrote to FDA Commissioner Dr. Margaret Hamburg in support of DaTscan’s approval and classification.